2023
DOI: 10.1002/bit.28312
|View full text |Cite
|
Sign up to set email alerts
|

Simple plant‐based production and purification of the assembled human ferritin heavy chain as a nanocarrier for tumor‐targeted drug delivery and bioimaging in cancer therapy

Abstract: Nanoparticles are used as carriers for the delivery of drugs and imaging agents.Proteins are safer than synthetic nanocarriers due to their greater biocompatibility and the absence of toxic degradation products. In this context, ferritin has the additional benefit of inherently targeting the membrane receptor transferrin 1, which is overexpressed by most cancer cells. Furthermore, this self-assembling multimeric protein can be loaded with more than 2000 iron atoms, as well as drugs, contrast agents, and other … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 117 publications
0
9
0
Order By: Relevance
“…It seemed implausible to us that these proteins would form aggregates due to the base salinity of the extraction buffer (~ 20 mS cm −1 ) at 22 °C. Instead, unspecific binding of proteins to depth filters containing diatomaceous earth has been reported before (Knödler et al 2023 ; Opdensteinen et al 2021 ), and we then assumed that electrostatic interactions between the proteins and the charged components of the depth filter caused the product losses as previously observed for other molecules (Menzel et al 2018 ). We therefore tested a set of depth filters that contained less diatomaceous earth (Fig.…”
Section: Resultsmentioning
confidence: 97%
“…It seemed implausible to us that these proteins would form aggregates due to the base salinity of the extraction buffer (~ 20 mS cm −1 ) at 22 °C. Instead, unspecific binding of proteins to depth filters containing diatomaceous earth has been reported before (Knödler et al 2023 ; Opdensteinen et al 2021 ), and we then assumed that electrostatic interactions between the proteins and the charged components of the depth filter caused the product losses as previously observed for other molecules (Menzel et al 2018 ). We therefore tested a set of depth filters that contained less diatomaceous earth (Fig.…”
Section: Resultsmentioning
confidence: 97%
“…Therefore, we have augmented our previous cost model (Buyel and Fischer, 2012; Fischer and Buyel, 2020; Knödler et al ., 2023) with various options in upstream plant production and downstream biomass processing (Table S4). Two general production scenarios were derived: (1) fully‐automated transient expression using a vertical farm in a middle‐ to high‐income country for the production of emergency or personalized medicines (automated/transient; e.g .…”
Section: Resultsmentioning
confidence: 99%
“…ICIs are revolutionary in cancer treatments (Tang et al, 2018), but efforts have to be made to improve accessibility, especially to LMICs, by lowering costs. Combination therapy to improve their efficacy (Khair et al, 2019;Ma et al, 2021) also necessitates separate manufacturing lines for each component, which can increase manufacturing costs. We believe ICIs can be made more economically feasible using plants, a relatively new but attractive alternative production platform to the current mammalian cellbased bioreactors (Moon et al, 2020;Paul et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As cell death featured by the accumulation of lethal lipid peroxides (LPO), ferroptosis can overcome the apoptosis resistance of classical therapeutics and holds great promise for cancer treatment. Since the production of LPO is derived from the iron-mediated Fenton reaction, which converts endogenous H 2 O 2 to hydroxyl radicals (·OH) that oxidize lipids, ferroptosis heavily relies on the intracellular iron ion level. , Currently, two strategies have been developed to supplement iron ions: one is the induction of intracellular ferritin degradation, and the other is the delivery of iron-based materials, such as zero-valent iron, iron oxide, , and iron-organic frameworks (MOFs). , However, there is a low content of intracellular ferritin (141.3–587.9 ng per mg of cytosol protein), and the iron-based materials easily cause adverse effects such as liver damage and chronic kidney disease at a dose as low as 5 mg/kg. Although the exogenous iron-containing proteins have superior biocompatibility and have been employed to supplement intracellular iron, their extraction, purification, and storage are complicated and costly, seriously hindering their clinical application. Therefore, the development of a new iron-supplement strategy to induce ferroptosis is urgent.…”
Section: Introductionmentioning
confidence: 99%